Organization
IRCCS San Raffaele Hospital, Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), Milan, Italy
2 abstracts
Abstract
A MULTINATIONAL SURVEY INVESTIGATING THE UNMET NEEDS AND PATIENT PERSPECTIVES CONCERNING PROTON PUMP INHIBITORS IN SYSTEMIC SCLEROSISOrg: University of Florence, Division of Internal Medicine, Department of Experimental and Clinical Medicine, Florence, Italy, University of L’Aquila, Internal Medicine and Nephrology Division, Department of Life Health and Environmental Science, L’Aquila, Italy, Centro Hospitalar Universitário de São João, Department of Rheumatology, Porto, Portugal, IRCCS San Raffaele Hospital, Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), Milan, Italy, FESCA (Federation of European Scleroderma Associations) Belgium, GILS (Gruppo Italiano Lotta alla Sclerodermia), Department of Rheumatology, Milan, Italy,
Abstract
A MULTINATIONAL, PROSPECTIVE, OBSERVATIONAL STUDY IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING BARICITINIB, TARGETED SYNTHETIC OR BIOLOGIC DISEASE-MODIFYING THERAPIES: 12 MONTH TIME TO DISCONTINUATION, EFFECTIVENESS AND PATIENT REPORTED OUTCOME DATA FROM THE EUROPEAN COHORTOrg: Schlosspark Klinik, Department of Internal Medicine and Rheumatology, Berlin, Germany, Charité Universitätsmedizin, Department of Rheumatology and Clinical Immunology, Indianapolis, United States of America, IRCCS San Raffaele Hospital, Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), Milan, Italy, University of Florence and Division of Rheumatology AOUC, Department of Experimental and Clinical Rheumatology, Florence, Italy, Monash University and Emeritus Research, Cabrini Hospital, Melbourne, Australia,